STOCKWATCH
·
Medical/Dental Instruments
Quarterly ResultApr 13, 2026, 08:11 AM

CVRx Q1 2026 Preliminary Revenue $14.7M-$14.8M, Gross Margin 87%

AI Summary

CVRx, Inc. announced preliminary financial results for the first quarter ended March 31, 2026. The company expects total revenue to be in the range of $14.7 million to $14.8 million, representing approximately 20% growth compared to the first quarter of 2025. Gross margin is anticipated to improve to about 87% from 84% in the prior year, while operating expenses are projected to be around $25 million. CVRx also reported an increase in U.S. active implanting centers to 257 and expanded its sales territories to 56.

Key Highlights

  • Q1 2026 preliminary revenue: $14.7M-$14.8M, up ~20% YoY.
  • Q1 2026 preliminary gross margin: ~87%, up from 84% YoY.
  • Q1 2026 preliminary operating expenses: ~$25M.
  • U.S. active implanting centers increased to 257.
  • U.S. sales territories expanded to 56.
CVRX
Medical/Dental Instruments
CVRx, Inc.

Price Impact